Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly for targeted cancer therapies. Its azide and cyano functional groups enable click chemistry reactions, facilitating rapid compound diversification and labeling for biochemical assays. The fluorinated hydroxypropanyl acetamide structure enhances binding specificity to certain protein targets, making it valuable in the development of proteolysis-targeting chimeras (PROTACs) and other targeted degradation agents. Commonly employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and metabolic stability.